Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related 		KEGG GENES KEGG DRUG DrugBank Disease ID
1 Cadherin signaling 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
2 Cadherin signaling 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
3 Cadherin signaling 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
4 Cadherin signaling 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
5 Cadherin signaling 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
6 Cadherin signaling 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
7 Cadherin signaling 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
8 Cadherin signaling 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
9 Cadherin signaling 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
10 Cadherin signaling 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
11 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
12 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
13 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
14 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
15 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
16 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
17 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
18 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
19 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
20 Calcium signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
21 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
22 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
23 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
24 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
25 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
26 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
27 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
28 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
29 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
30 Central carbon metabolism in cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
31 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
32 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
33 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
34 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
35 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
36 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
37 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
38 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
39 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
40 Choline metabolism in cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
41 Endocytosis 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
42 Endocytosis 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
43 Endocytosis 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
44 Endocytosis 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
45 Endocytosis 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
46 Endocytosis 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
47 Endocytosis 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
48 Endocytosis 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
49 Endocytosis 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
50 Endocytosis 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
51 Focal adhesion 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
52 Focal adhesion 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
53 Focal adhesion 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
54 Focal adhesion 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
55 Focal adhesion 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
56 Focal adhesion 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
57 Focal adhesion 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
58 Focal adhesion 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
59 Focal adhesion 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
60 Focal adhesion 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
61 Gap junction 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
62 Gap junction 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
63 Gap junction 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
64 Gap junction 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
65 Gap junction 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
66 Gap junction 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
67 Gap junction 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
68 Gap junction 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
69 Gap junction 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
70 Gap junction 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
71 Glioma 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
72 Glioma 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
73 Glioma 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
74 Glioma 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
75 Glioma 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
76 Glioma 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
77 Glioma 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
78 Glioma 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
79 Glioma 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
80 Glioma 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
81 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
82 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
83 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
84 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
85 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
86 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
87 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
88 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
89 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
90 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
91 Integrin signaling 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
92 Integrin signaling 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
93 Integrin signaling 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
94 Integrin signaling 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
95 Integrin signaling 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
96 Integrin signaling 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
97 Integrin signaling 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
98 Integrin signaling 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
99 Integrin signaling 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
100 Integrin signaling 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
101 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
102 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
103 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
104 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
105 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
106 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
107 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
108 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
109 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
110 JAK-STAT signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
111 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
112 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
113 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
114 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
115 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
116 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
117 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
118 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
119 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
120 MAPK signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
121 Melanoma 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
122 Melanoma 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
123 Melanoma 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
124 Melanoma 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
125 Melanoma 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
126 Melanoma 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
127 Melanoma 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
128 Melanoma 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
129 Melanoma 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
130 Melanoma 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
131 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
132 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
133 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
134 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
135 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
136 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
137 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
138 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
139 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
140 MicroRNAs in cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
141 Pathways in cancer 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
142 Pathways in cancer 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
143 Pathways in cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
144 Pathways in cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
145 Pathways in cancer 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
146 Pathways in cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
147 Pathways in cancer 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
148 Pathways in cancer 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
149 Pathways in cancer 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
150 Pathways in cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
151 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
152 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
153 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
154 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
155 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
156 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
157 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
158 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
159 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
160 Phospholipase D signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
161 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
162 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
163 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
164 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
165 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
166 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
167 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
168 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
169 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
170 PI3K-Akt signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
171 Prostate cancer 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
172 Prostate cancer 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
173 Prostate cancer 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
174 Prostate cancer 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
175 Prostate cancer 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
176 Prostate cancer 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
177 Prostate cancer 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
178 Prostate cancer 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
179 Prostate cancer 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
180 Prostate cancer 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
181 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
182 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
183 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
184 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
185 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
186 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
187 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
188 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
189 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
190 Rap1 signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
191 Ras signaling pathway 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
192 Ras signaling pathway 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
193 Ras signaling pathway 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
194 Ras signaling pathway 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
195 Ras signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
196 Ras signaling pathway 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
197 Ras signaling pathway 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
198 Ras signaling pathway 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
199 Ras signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
200 Ras signaling pathway 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬
201 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Catequentinib 💬 Anlotinib [1] 85 💬
202 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Imatinib mesylate 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
203 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Imatinib 💬 Imatinib [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
204 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Nilotinib 💬 Nilotinib [5]  6 ,  8 , 34, 51, 86 💬
205 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Nintedanib esylate 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
206 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Nintedanib 💬 Nintedanib [7] 51, 84, 85, 89, 227, 228, 331 💬
207 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Pazopanib hydrochloride 💬 Pazopanib [1] 227 💬
208 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Seralutinib 💬 Seralutinib [1] 86 💬
209 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Sunitinib malate 💬 Sunitinib [2] 28, 34 💬
210 Regulation of actin cytoskeleton 💬
 [1] PDGFRA 💬 Sunitinib 💬 Sunitinib [2] 28, 34 💬

Back to top